Experts warn federal spending cuts will make the country sicker and poorer as healthcare costs rise without new treatments.

Epilepsy researcher Sujithra Srinivas discusses the value of translational research for understanding and treating neurologic ...

Xenon Pharmaceuticals (($XENE)) has held its Q4 earnings call. Read on for the main highlights of the call. Xenon Pharmaceuticals’ recent earnings ...

“The addition of these five esteemed scientists to our SAB reflects our deepening clinical focus on epilepsy ... These factors include the company’s financial position and operational runway ...

He leads a large translational research team undertaking both basic studies and clinical studies focused on developing improved treatments for people with epilepsy and related brain diseases ...

Detailed price information for Bright Minds Biosciences Inc (DRUG-Q) from The Globe and Mail including charting and trades.